ACUAMARK DIAGNOSTICS, INC.

Profile

Company Names

ACUAMARK DIAGNOSTICS, INC.

Addresses

101 AVENUE OF THE AMERICAS, FLOOR 13 (C/O JLABS), NEW YORK, NY 10020

101 AVENUE OF THE AMERICAS, FLOOR 3 (C/O JLABS), NEW YORK, NY 10013

17 JOHN STREET, NEW YORK, NY 10038

369 LEXINGTON AVENUE, FLOOR 26, NEW YORK, NY 10017

Phone Numbers

646-640-7865
212-972-0077

 

Entity Type:

CORPORATION

Industry:

OTHER HEALTH CARE, OTHER, OTHER TECHNOLOGY

Year Incorporated:

2012

State Incorporated:

NEW YORK

Total Amount Raised:

$20,333,197.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2024-05-22 
$4,941,620.00 
$11,999,983.00 
$7,058,363.00 
Equity 
3
2022-03-21 
$11,623,242.00 
$13,648,253.00 
$2,025,011.00 
Equity 
2
2019-09-10 
$2,289,501.00 
$5,315,765.00 
$3,026,264.00 
Equity 
1
2016-09-01 
$1,478,834.00 
$1,700,000.00 
$221,166.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
BRIAN 
 
CARR 
DIRECTOR
MORGAN STANLEY REAL ESTATE FUND VII GLOBAL-F, L.P.   |  HIGHBROOK INCOME PROPERTY FUND, LP   |  HIGHBROOK INCOME PROPERTY SPONSOR FUND, LP   |  REGIONAL DIAGNOSTIC LABORATORIES, INC.   |  GOOD TECHNOLOGY CORP   |  JC IRVING PARENT, LLC   |  6610 CABOT PARENT, LLC   |  SUGARCRAFT PARENT, LLC   |  ONE CHESTERFIELD PARENT, LLC   |  CHRONOS RESOURCES LTD.   |  EXCHANGE SOUTH HOLDINGS, LLC   |  302 WEST THIRD PARENT, LLC   |  ACUAMARK DIAGNOSTICS, INC.   |  HIGHBROOK INCOME PROPERTY FUND REIT II B, LLC   |  150 FAYETTEVILLE PARTNERS, LLC   |  MF PORTFOLIO PARENT, LLC
CLAUDIO 
 
DEL VECCHIO 
DIRECTOR
ACUAMARK DIAGNOSTICS, INC.   |  SWAPRETAIL, INC.
CEDRIC 
 
FRANCOIS 
DIRECTOR
APELLIS PHARMACEUTICALS, INC.   |  NX PHARMAGEN INC.   |  REVON SYSTEMS, LLC   |  REVON SYSTEMS, INC.   |  LIBERATE MEDICAL, INC.   |  ACUAMARK DIAGNOSTICS, INC.
MICHAEL 
 
GARGANO 
DIRECTOR
COFERON, INC.   |  BLINKBIO, INC.   |  ACUAMARK DIAGNOSTICS, INC.
WILLIAM 
 
GEDALE 
DIRECTOR
KIKA MEDICAL INTERNATIONAL CO   |  ACUAMARK DIAGNOSTICS, INC.
MICHAEL 
 
HANBURY 
DIRECTOR
HEALTH DISCOVERY CORP   |  VANTAGEPOINT HOLDINGS, INC.   |  ACUAMARK DIAGNOSTICS, INC.
HOWARD 
 
JOHNSON 
DIRECTOR
ACUAMARK DIAGNOSTICS, INC.
GIULIA 
 
KENNEDY 
DIRECTOR
ASTARTE MEDICAL PARTNERS, INC.   |  ACUAMARK DIAGNOSTICS, INC.
GREGORY 
 
MURDOCK 
DIRECTOR
NX DEVELOPMENT CORP.   |  NQ MEDICAL, INC.   |  ACUAMARK DIAGNOSTICS, INC.
BERNARD 
 
PEPERSTRAETE 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
ACUAMARK DIAGNOSTICS, INC.   |  VISUM PHARMA, INC.
JOSEPH 
 
SMITH 
DIRECTOR
ING CLARION U.S., LP   |  ING CLARION GLOBAL, LP   |  ING CLARION MARKET NEUTRAL, LP   |  ING CLARION GLOBAL, LTD.   |  ING CLARION U.S., LTD.   |  SUCCEED ON BROADWAY LTD LIABILITY CO   |  CBRE CLARION U.S., LP   |  CBRE CLARION GLOBAL, LP   |  CBRE CLARION GLOBAL, LTD.   |  TENDYNE HOLDINGS, INC.   |  SVELTE MEDICAL SYSTEMS INC   |  LABCYTE INC   |  OCUDYNE, INC.   |  PHENOM PEOPLE, INC.   |  ACUAMARK DIAGNOSTICS, INC.   |  PARTI PRIS INVESTMENT PARTNERS, INC.
VANJA 
 
VULETIC 
DIRECTOR
ACUAMARK DIAGNOSTICS, INC.
DAVID 
 
WEAVIL 
DIRECTOR
ACUAMARK DIAGNOSTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-06-04
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2024-05-22 
2022-04-06
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2022-03-21 
2019-09-25
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2019-09-10 
2016-11-17
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-09-01 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
FINALIS SECURITIES LLC
305908